Team

Douglas S. Hamilton, Chief Executive Officer

Douglas S. Hamilton is a Co-Founder and the Chief Executive Officer of i3 Pharmaceuticals, LLC and Pontis Pharma, LLC. Previously, in 2004, he Co-Founded and held the position of President at Synerx Pharma, LLC, a specialty generic pharmaceutical company which was sold to Mylan Laboratories in 2011. Over his 30+ year career, he has held senior executive positions in Sourcing, New Product Development/Commercialization, Manufacturing and Business Development at leading pharmaceutical companies including Lederle Labs (now Pfizer), Bristol Myers Squibb, Novartis/Sandoz and Sanofi – Aventis. Mr. Hamilton holds a B.S. degree in Chemical Engineering from the New Jersey Institute of Technology as well as an MBA from Fairleigh Dickinson University.

Ram K. Kallur, Vice President, Operations & Sourcing

Ram K. Kallur is a Co-Founder and the Vice President of Operations and Sourcing at i3 Pharmaceuticals, LLC and Pontis Pharma, LLC. Prior to that, he was a member and the Senior Vice President of Operations at Sigmapharm Laboratories, LLC. Ram worked at Pfizer as a Scientist, Process Development and worked for URL Pharma, Inc. (formerly URL/Mutual) as a formulation scientist and at Core Pharma as a Scientist, Analytical Research and Development. He has more than 16 years of diversified experience in pharmaceutical industry, where he gained experience in product and process development, analytical testing, quality assurance, process validation, commercial manufacturing, new product launch and engineering aspects of facility. Ram, as a team member and individually developed submitted, validated and launched several unique generic and paragraph IV drug products using his scientific, technical and quality oriented expertise. Mr. Kallur holds a M.S. degree in Industrial Pharmacy from the Arnold and Marie Schwartz College of Pharmacy of Long Island University and a B.S. degree in Pharmacy from Mangalore University, India.

Sunil V. Sagi, Vice President, Scientific & Regulatory Affairs

Sunil V. Sagi is a Co-Founder and the Vice President of Scientific and Regulatory Affairs of i3 Pharmaceuticals, LLC and Pontis Pharma, LLC. Prior to that, he was a member and the Senior Vice President of Technology Development at Sigmapharm Laboratories, LLC and worked for URL Pharma, Inc. (formerly URL/Mutual) as the Manager of Technology Development, R&D. He has 16 years of experience in Research and Development and Regulatory Affairs and has successfully developed, submitted, validated and launched several unique generic and paragraph IV drug products. Mr. Sagi holds a M.S. degree in Industrial Pharmacy from the Arnold and Marie Schwartz College of Pharmacy of Long Island University and a B.S. degree in Pharmacy from Mangalore University, India.

Ishari P. Shrestha, Vice President, Research & Development

Ishari Piya Shrestha is a Co-Founder and the Vice President of Research and Development of i3 Pharmaceuticals, LLC and Pontis Pharma, LLC. Prior to that, she was a member and the Senior Vice President of Product Development at Sigmapharm Laboratories, LLC. She worked for Kali Laboratories (Presently Par Pharmaceuticals) and URL Pharma, Inc. (formerly URL/Mutual) as the Manager of Product Development, R&D. She has 16+ years of experience in Research and Development and has successfully developed, submitted, validated and launched several unique generic and paragraph IV drug products. Ms. Shrestha holds a M.S. degree in Industrial Pharmacy from the Arnold and Marie Schwartz College of Pharmacy of Long Island University and a B.S. degree in Pharmacy from University of Sind, Pakistan. 

Jhansi L. Lakkaraju, Vice President, Quality Assurance & Analytical Services

Jhansi L. Lakkaraju is a member and the Vice President of QA & Analytical Services, at i3 Pharmaceuticals, LLC and Pontis Pharma, LLC.  Prior to that, she was the Vice President of Research and Development at Tris Pharma, LLC.  She worked as a Principal Scientist, Analytical Research and Development at Actavis and was a group leader, AR&D at Pharmaceutics International Inc.  She has over 19 years of research and development experience in development of generic and brand products. During these years, she developed expertise in preparing CMC documentation, addressing information requests, complete response letters for NDA and ANDA submissions including first to file products.  Ms. Jhansi holds a Ph.D. degree in Chemistry from Indian Institute of Chemical Technology, India and has done post-doctoral research at the Department of Chemistry and Bio-chemistry, University of Guelph, and Department of Chemistry, Brock University, Ontario, Canada.